NT5C1A and myositis disease: In a retrospective cohort of 1,194 patients, patients were compared to healthy controls for the presence of anti-Ha, anti-Ks, anti-Zoα, cN1A novel myositis autoantibodies and found that the prevalence of ILD was significantly higher in those with novel myositis antibodies.